Trospium chloride

When ATH:
G04BD09

Characteristic.

Chetvertichnoe ammonievoe ground.

Pharmacological action.
Holinoliticheskoe, antispasmodic.

Application.

Thamuria, nocturia, urinary incontinence non-hormonal and non-organic etiology, spastic neurogenic bladder disorders, incl. giperrefleksiâ detrusor at rasseânnom sclerosis.

Contraindications.

Hypersensitivity, prostate adenoma, bladder carcinoma, Mechanical stenosis of the gastrointestinal tract, zakrыtougolynaya glaucoma, integuments, myasthenia, pregnancy, lactation.

Restrictions apply.

Childhood (safety and effectiveness in children have not identified).

Pregnancy and breast-feeding.

Contraindicated in pregnancy. At the time of treatment should stop breastfeeding.

Side effects.

Dry mouth, ccomodation eye.

Cooperation.

Potentiates the effect of amantadine, tricyclic antidepressants, xinidina, blokatorov gistaminovyh N₁-receptors, dizopiramida, beta-agonists.

Dosing and Administration.

Inside, the dosage regimen and duration of therapy are set individually; usually 5, 15 or 30 mg 2-3 times a day. Patients older appoint 5 mg 2-3 times a day.

Precautions.

If any of the detrusor sphincter should ensure complete emptying of the bladder by catheterization. When autonomic dysfunction of the bladder cause must be established prior to initiating therapy. Before the appointment of the drug to rule out a urinary tract infection and bladder carcinoma. Should not be used during the drivers of vehicles and people, skills relate to the high concentration of attention.

Cooperation